From the Department of Surgery, Division of Plastic Surgery, University of Wisconsin School of Medicine and Public Health.
Plast Reconstr Surg. 2020 Sep;146(3):681-689. doi: 10.1097/PRS.0000000000007221.
Coronavirus disease 2019 (COVID-19), a novel coronavirus originating in December of 2019 in Wuhan, People's Republic of China, has spread rapidly throughout the globe over 3 months. On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. COVID-19 represents a nearly unprecedented threat to both the public health and the durability of our health care systems and will profoundly affect the field of plastic and reconstructive surgery. The objective of this article is to provide a natural history of COVID-19-including virology, epidemiology, and transmission patterns-and a guide for plastic surgeons regarding patient and resource management.
The authors reviewed existing literature regarding COVID-19, both primary research and secondary reviews, by means of PubMed queries, and recommendations from relevant professional organizations (e.g., American College of Surgeons and American Society of Plastic Surgeons). The literature and recommendations were summarized to provide a specific guide for plastic surgeons.
Internationally, over 5.7 million cases and 357,000 deaths from COVID-19 have been reported at the time of writing. No pharmacologic treatments have been identified, but epidemiologic strategies were identified to prevent viral spread, preserve health care resources, and protect patients and surgeons globally. Specific recommendations for plastic and reconstructive surgeons include postponing elective cases and transitioning to telecommunication platforms for patient consultations and education.
COVID-19 represents a nearly unprecedented threat to the public health and the durability of health care systems in the contemporary era. Although plastic and reconstructive surgery may seem relatively remote from the pandemic in direct patient care and exposure, our field can significantly enhance health care resource management.
2019 年 12 月起源于中华人民共和国武汉市的 2019 年冠状病毒病(COVID-19)在 3 个月内迅速在全球蔓延。2020 年 3 月 11 日,世界卫生组织宣布 COVID-19 为全球大流行。COVID-19 对公共卫生和我们的医疗保健系统的耐久性构成了几乎前所未有的威胁,并将深刻影响整形和重建外科学领域。本文的目的是提供 COVID-19 的自然史,包括病毒学、流行病学和传播模式,并为整形外科医生提供有关患者和资源管理的指南。
作者通过 PubMed 查询和相关专业组织(例如美国外科医师学会和美国整形外科学会)的建议,对 COVID-19 的现有文献进行了综述,包括主要研究和二级综述。对文献和建议进行了总结,为整形外科医生提供了具体的指南。
截至撰写本文时,全球已报告超过 570 万例 COVID-19 病例和 35.7 万例死亡。虽然尚未发现任何药物治疗方法,但已经确定了流行病学策略来防止病毒传播、保护医疗资源以及保护全球患者和外科医生。对整形和重建外科医生的具体建议包括推迟选择性病例,并过渡到远程通信平台进行患者咨询和教育。
COVID-19 对当代公共卫生和医疗保健系统的耐久性构成了几乎前所未有的威胁。尽管在直接的患者护理和暴露方面,整形和重建外科学似乎相对远离大流行,但我们的领域可以极大地增强医疗资源管理。